Skip Navigation

Strengthen the Evidence for Maternal and Child Health Programs

Sign up for MCHalert eNewsletter

Search Results: MCHLine

Items in this list may be obtained from the sources cited. Contact information reflects the most current data about the source that has been provided to the MCH Digital Library.

Displaying records 1 through 10 (10 total).

Partnership for Drug-Free Kids. n.d.. Pregnancy and opioids: What families need to know about opioid misuse and treatment during pregnancy. New York, NY: Partnership for Drug-Free Kids, 20 pp.

Annotation: This guide provides information for a pregnant woman’s family about opioid misuse and treatment during pregnancy. The guide explains what an opioid use disorder is and discusses the importance of comprehensive prenatal care and treatment for pregnant women with the disorder, delivery, newborn health, breastfeeding, social supports, and what to expect in the weeks and months after delivery.

Contact: Partnership for Drug-Free Kids, 352 Park Avenue South, 9th Floor, New York, NY 10010, Telephone: (855) 378-4373 Secondary Telephone: (212) 922-1560 Fax: (212) 922-1570 E-mail: [email protected] Web Site: http://www.drugfree.org/ Available from the website.

Keywords: Consumer education materials, Infant health, Narcotics, Perinatal addiction, Pregnant women, Substance abuse treatment

Barzel R, Holt K, Kolo S. 2022. Opioids and pregnant women: Information for oral health professionals. Washington, DC: National Maternal and Child Oral Health Resource Center, 4 pp.

Annotation: This practice guidance provides an overview of pain management for dental procedures for women of reproductive age. It discusses pharmacological considerations for pregnant women (pharmaceutical agents and indications, contraindications, and special considerations), neonatal opioid withdrawal syndrome, guidelines for providing opioids, managing acute dental pain, and guidelines for discharging women with opioid prescriptions. Information about prescription drug monitoring programs is included. [Funded by the Maternal and Child Health Bureau]

Contact: National Maternal and Child Oral Health Resource Center, Georgetown University, Washington, DC 20057, E-mail: [email protected] Web Site: https://www.mchoralhealth.org Available from the website.

Keywords: Drug addiction, Guidelines, Narcotics, Neonatal abstinence syndrome, Oral health, Pain relieving drugs, Pregnant women, Prescription drugs

Barzel R, Holt K. 2022. Opioids and children and adolescents: Information for oral health professionals. Washington, DC: National Maternal and Child Oral Health Resource Center, 6 pp.

Annotation: This document provides guidance on opioids for oral health professionals. It includes information about assessing children and adolescents, drugs to recommend before prescribing opioids, prescribing opioids with caution and being aware of the potential for misuse or abuse, and understanding laws, policies, and recommendations. The document also discusses providing post-operative instructions and creating a safe, friendly environment. Information about prescription-drug-monitoring programs and managing acute oral pain are included, along with tips for dentists to share with parents and an overview of research. [Funded by the Maternal and Child Health Bureau]

Contact: National Maternal and Child Oral Health Resource Center, Georgetown University, Washington, DC 20057, E-mail: [email protected] Web Site: https://www.mchoralhealth.org Available from the website.

Keywords: Adolescent health, Child health, Drug abuse, Narcotics, Oral health, Pain, Prescription drugs, Prevention

Singh AD, and Association of State and Territorial Dental Directors, Dental Public Health Policy Committee . 2021. Policy statement: Reducing opioid prescribing by oral health professionals. Reno, NV: Association of State and Territorial Dental Directors, 13 pp.

Annotation: This statement provides data related to reducing opioid prescribing by oral health professionals and highlights policies and strategies, including the introduction, adoption, and promotion of prescribing guidelines by the American Dental Association and the Centers for Disease Control and Prevention. Also discussed are state requirements for dentist participation in prescription drug monitoring programs, continuing education for oral health professionals related to pain management, and inclusion of pain-management approaches in dental education. The statement also highlights how state oral health programs have identified and engaged in promising and effective approaches related to opioid prescription practices.

Contact: Association of State and Territorial Dental Directors, 3858 Cashill Boulevard, Reno, NV 89509, Telephone: (775) 626-5008 Fax: (775) 626-9268 E-mail: [email protected] Web Site: https://www.astdd.org Available from the website.

Keywords: Dental education, Health policy, Narcotics, Oral health, Pain management, Prescription drugs, Public policy, State programs

Ashburn, M et al. 2019. Opioids in the dental practice (rev.). Harrisburg, PA: Commonwealth of Pennsylvania; in partnership with the Pennsylvania Dental Association, 6 pp. (Prescribing guidelines for Pennsyvania)

Annotation: These guidelines for prescribing opiods in dental practices in Pennsylvania, which update guidelines published in 2014, address the use of opioids for the treatment of oral pain. The guidelines are intended to help oral health professionals improve patient outcomes. Topics include recommendations for treatment of acute, subacute, and post-operative pain and treatment of chronic pain.

Contact: Pennsylvania Department of Health, Health and Welfare Building, 625 Forster Street, Eighth Floor West, Harrisburg, PA 17120, Telephone: (877) 724-3258 Web Site: http://www.health.pa.gov Available from the website.

Keywords: Chronic pain, Guidelines, Narcotics, Oral health, Pain, Pain relieving drugs, Pennsylvania, State information

American Dental Association Health Policy Institute. 2018. Opioid prescribing by dentists. Chicago, IL: American Dental Association Health Policy Institute, 1 p.

Annotation: This infographic provides information about trends in the percentages of opioids prescribed by dentists to individuals with private dental insurance between 2010 and 2015. Total percentages are provided, as well as percentages by age group. Information about days’ supply and quantities of pills prescribed by dentists to individuals with private insurance for 2010–2015 is also presented.

Contact: American Dental Association, Health Policy Institute, 211 East Chicago Avenue, Chicago, IL 60611-2678, Telephone: (312) 440-2500 Web Site: http://www.ada.org/en/science-research/health-policy-institute

Keywords: , Narcotics, Oral health, Oral health care, Prescription Drugs, Statistical data, Trends

Oregon Pregnancy and Opioids Workgroup. 2018. Oregon Pregnancy and Opioids Workgroup recommendations. Salem, OR: Oregon Health Authority, Public Health Division, 27 pp.

Annotation: This document provides recommendations for the management of opioid use for pregnant women, including pregnant women with opioid-use disorder, and for care of the opioid-exposed newborn. Topics include clinical recommendations, health-systems and policy recommendations, definitions, and resources and collaborative approaches.

Contact: Oregon Health Authority, Public Health Division , 800 NE Oregon Street, Portland , OR 97232, Telephone: 971-673-0252 Secondary Telephone: Fax: (503) 947-2341 E-mail: [email protected] Web Site: https://www.oregon.gov/OHA/PH/Pages/index.aspx Available from the website.

Keywords: Narcotics, Oral health, Oregon, Pregnant women, Prescription drugs, State programs, Substance abuse, Substance dependence

U.S. Substance Abuse and Mental Health Services Administration. 2018. Clinical guidance for treating pregnant and parenting women with opioid use disorder and their infants. Rockville, MD: U.S. Substance Abuse and Mental Health Services Administration, 159 pp.

Annotation: This guide provides guidance for the optimal management of pregnant and parenting women with opioid use disorder (OUD) and their infants, based on recommendations of experts as of 2017. The guide is designed to help health professionals and women determine the most clinically appropriate action for a particular circumstance. In addition to offering background information, the guide includes fact sheets divided into the following sections: prenatal care, infant care, and maternal postnatal care. Each fact sheet includes a clinical scenario, clinical action steps, supporting evidence and clinical considerations, and links to and descriptions of online resources on the topic.

Contact: U.S. Substance Abuse and Mental Health Services Administration, One Choke Cherry Road, Rockville, MD 20857, Telephone: (877) SAMHSA-7 Secondary Telephone: (877) 726-4727 E-mail: Web Site: https://www.samhsa.gov Available from the website. Document Number: (SMA) 18-5054. .

Keywords: Guidelines, Narcotics, Parents, Perinatal addiction, Pregnant women, Prenatal addiction, Substance dependence, Substance use disorders, Treatment

Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE. 2000-. Monitoring the Future: National results on adolescent drug use—Overview of key findings, 20__. Ann Arbor, MI: University of Michigan, Institute for Social Research, annual.

Annotation: This annual report analyzes the results of an annual, national survey on drug use among 8th, 10th and 12th graders. Trends of use, perceived risk, disapproval, and availability frame the discussion for each substance examined, and tables illustrate the discussion.

Keywords: Adolescents, Alcohols, Amphetamines, Cocaine, Drug education, Hallucinogens, Heroin, High risk adolescents, Illicit drugs, Inhalants, Marijuana, Narcotics, National surveys, Risk taking, Sedatives, Statistics, Steroids, Substance abuse, Youth

Rogers PD, ed. 1987. Chemical dependency. Philadelphia, PA: W. B. Saunders Company, 270 pp. (Pediatric clinics of North America; v.34, no. 2)

Annotation: This book contains 18 articles on adolescents and drug and/or alcohol use. The articles were written for physicians who encounter adolescents in their practice. The information is intended to help physicians in their approach to the adolescent who may be abusing psychoactive substances and may, indeed, be chemically dependent.

Contact: Elsevier, Health Sciences Division, 1600 John F. Kennedy Boulevard, Suite 1800, Philadelphia, PA 19103-2822, Telephone: (215) 239-3900 Fax: (215) 239-3990 Web Site: http://www.us.elsevierhealth.com Available in libraries.

Keywords: Adolescent attitudes, Adolescent health, Alcohol consumption behavior, Alcoholic beverages, Cocaine, Drug dependence, Drug use, Hallucinogens, Marijuana, Narcotics, Screening, Smoking
   

This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U02MC31613, MCH Advanced Education Policy, $3.5 M. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.